Please login to the form below

Not currently logged in
Email:
Password:

Verzenio

This page shows the latest Verzenio news and features for those working in and with pharma, biotech and healthcare.

Lilly boosted by survival data for key growth drug Verzenio

Lilly boosted by survival data for key growth drug Verzenio

Chases Pfizer's Ibrance. Eli Lilly has the data readout it wanted to keep new breast cancer drug Verzenio firmly on a growth track as it chases after class leader Ibrance ... In the study, Verzenio (abemaciclib) – given alongside hormonal drug

Latest news

More from news
Approximately 7 fully matching, plus 7 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

PANDAS/PANS Awareness: A parent’s story
To help raise awareness of these often underdiagnosed diseases, Jon Hallows, Joint MD at Porterhouse shares his own experience as a parent of a son recently diagnosed with PANDAS...
Iskra Reic
Leading AstraZeneca’s return to growth in Europe
PME talks to Iskra Reic, the company’s head of Europe and Canada...
The era of digital wellbeing
Social media - friend or foe?...

Infographics